PT1658293E - Método de preparação de oxicodona - Google Patents
Método de preparação de oxicodona Download PDFInfo
- Publication number
- PT1658293E PT1658293E PT05776280T PT05776280T PT1658293E PT 1658293 E PT1658293 E PT 1658293E PT 05776280 T PT05776280 T PT 05776280T PT 05776280 T PT05776280 T PT 05776280T PT 1658293 E PT1658293 E PT 1658293E
- Authority
- PT
- Portugal
- Prior art keywords
- hydroxycodeinone
- acid
- oxycodone
- thebaine
- hydrogen peroxide
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 40
- BRUQQQPBMZOVGD-XFKAJCMBSA-N Oxycodone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(OC)C2=C5[C@@]13CCN4C BRUQQQPBMZOVGD-XFKAJCMBSA-N 0.000 title claims abstract description 33
- 229960002085 oxycodone Drugs 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims abstract description 44
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 39
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims abstract description 39
- FQXXSQDCDRQNQE-UHFFFAOYSA-N markiertes Thebain Natural products COC1=CC=C2C(N(CC3)C)CC4=CC=C(OC)C5=C4C23C1O5 FQXXSQDCDRQNQE-UHFFFAOYSA-N 0.000 claims abstract description 32
- 229930003945 thebaine Natural products 0.000 claims abstract description 32
- FQXXSQDCDRQNQE-VMDGZTHMSA-N thebaine Chemical compound C([C@@H](N(CC1)C)C2=CC=C3OC)C4=CC=C(OC)C5=C4[C@@]21[C@H]3O5 FQXXSQDCDRQNQE-VMDGZTHMSA-N 0.000 claims abstract description 31
- YYCRAERBSFHMPL-XFKAJCMBSA-N (4r,4as,7ar,12bs)-4a-hydroxy-9-methoxy-3-methyl-2,4,7a,13-tetrahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one Chemical compound O=C([C@@H]1O2)C=C[C@@]3(O)[C@]4([H])N(C)CC[C@]13C1=C2C(OC)=CC=C1C4 YYCRAERBSFHMPL-XFKAJCMBSA-N 0.000 claims abstract description 24
- YYCRAERBSFHMPL-UHFFFAOYSA-N 14beta-Hydroxycodeinone Natural products O1C2C(=O)C=CC3(O)C4CC5=CC=C(OC)C1=C5C23CCN4C YYCRAERBSFHMPL-UHFFFAOYSA-N 0.000 claims abstract description 24
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims abstract description 24
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims abstract description 12
- 235000019253 formic acid Nutrition 0.000 claims abstract description 12
- 235000006408 oxalic acid Nutrition 0.000 claims abstract description 12
- PQHXQKZCTZETAY-RKXJKUSZSA-N (4r,4as,7ar,12bs)-4a-hydroxy-9-methoxy-3-methyl-2,4,7a,13-tetrahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;oxalic acid Chemical compound OC(=O)C(O)=O.O=C([C@@H]1O2)C=C[C@@]3(O)[C@H]4CC5=CC=C(OC)C2=C5[C@@]13CCN4C PQHXQKZCTZETAY-RKXJKUSZSA-N 0.000 claims abstract description 10
- 239000002244 precipitate Substances 0.000 claims abstract description 8
- 239000003054 catalyst Substances 0.000 claims abstract description 7
- 239000001257 hydrogen Substances 0.000 claims abstract description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 6
- -1 methoxybenzyl Chemical group 0.000 claims abstract description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims abstract description 4
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims abstract description 3
- 125000002877 alkyl aryl group Chemical group 0.000 claims abstract description 3
- 238000006243 chemical reaction Methods 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 239000011541 reaction mixture Substances 0.000 claims description 13
- 150000007524 organic acids Chemical class 0.000 claims description 11
- BQNSLJQRJAJITR-UHFFFAOYSA-N 1,1,2-trichloro-1,2-difluoroethane Chemical compound FC(Cl)C(F)(Cl)Cl BQNSLJQRJAJITR-UHFFFAOYSA-N 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 10
- 229960003617 oxycodone hydrochloride Drugs 0.000 claims description 10
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 claims description 8
- 238000005119 centrifugation Methods 0.000 claims description 7
- 239000007864 aqueous solution Substances 0.000 claims description 4
- YNJSNEKCXVFDKW-UHFFFAOYSA-N 3-(5-amino-1h-indol-3-yl)-2-azaniumylpropanoate Chemical compound C1=C(N)C=C2C(CC(N)C(O)=O)=CNC2=C1 YNJSNEKCXVFDKW-UHFFFAOYSA-N 0.000 claims description 3
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 2
- 238000010908 decantation Methods 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract description 8
- 239000000203 mixture Substances 0.000 abstract description 7
- 239000004480 active ingredient Substances 0.000 abstract description 2
- 230000000202 analgesic effect Effects 0.000 abstract description 2
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000047 product Substances 0.000 description 12
- 230000008569 process Effects 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 238000007254 oxidation reaction Methods 0.000 description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- XYYVYLMBEZUESM-CMKMFDCUSA-N codeinone Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=CC(=O)[C@@H]1OC1=C2C3=CC=C1OC XYYVYLMBEZUESM-CMKMFDCUSA-N 0.000 description 6
- 230000003647 oxidation Effects 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 239000013078 crystal Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- XYYVYLMBEZUESM-UHFFFAOYSA-N dihydrocodeine Natural products C1C(N(CCC234)C)C2C=CC(=O)C3OC2=C4C1=CC=C2OC XYYVYLMBEZUESM-UHFFFAOYSA-N 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000007800 oxidant agent Substances 0.000 description 3
- 229910052763 palladium Inorganic materials 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000005251 capillar electrophoresis Methods 0.000 description 2
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 2
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 239000012429 reaction media Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- YYCRAERBSFHMPL-FSFXSCMFSA-N (4r,4as,12bs)-4a-hydroxy-9-methoxy-3-methyl-2,4,7a,13-tetrahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one Chemical compound O1C2C(=O)C=C[C@@]3(O)[C@H]4CC5=CC=C(OC)C1=C5[C@@]23CCN4C YYCRAERBSFHMPL-FSFXSCMFSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 101001068027 Homo sapiens Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform Proteins 0.000 description 1
- 150000001204 N-oxides Chemical class 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 240000001090 Papaver somniferum Species 0.000 description 1
- 229910002666 PdCl2 Inorganic materials 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 102100034464 Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform Human genes 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000004103 aminoalkyl group Chemical group 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Inorganic materials [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229960004126 codeine Drugs 0.000 description 1
- 150000001993 dienes Chemical class 0.000 description 1
- 238000002050 diffraction method Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 150000002084 enol ethers Chemical class 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 229940071125 manganese acetate Drugs 0.000 description 1
- UOGMEBQRZBEZQT-UHFFFAOYSA-L manganese(2+);diacetate Chemical compound [Mn+2].CC([O-])=O.CC([O-])=O UOGMEBQRZBEZQT-UHFFFAOYSA-L 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- UZHSEJADLWPNLE-GRGSLBFTSA-N naloxone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(O)C2=C5[C@@]13CCN4CC=C UZHSEJADLWPNLE-GRGSLBFTSA-N 0.000 description 1
- 229960004127 naloxone Drugs 0.000 description 1
- DQCKKXVULJGBQN-XFWGSAIBSA-N naltrexone Chemical compound N1([C@@H]2CC3=CC=C(C=4O[C@@H]5[C@](C3=4)([C@]2(CCC5=O)O)CC1)O)CC1CC1 DQCKKXVULJGBQN-XFWGSAIBSA-N 0.000 description 1
- 229960003086 naltrexone Drugs 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000004967 organic peroxy acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000005588 protonation Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 238000010583 slow cooling Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
- C07D489/08—Oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SK321-2004A SK286087B6 (sk) | 2004-08-18 | 2004-08-18 | Spôsob prípravy oxykodonu |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1658293E true PT1658293E (pt) | 2007-01-31 |
Family
ID=34993096
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT05776280T PT1658293E (pt) | 2004-08-18 | 2005-08-16 | Método de preparação de oxicodona |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7619087B2 (cs) |
| EP (1) | EP1658293B1 (cs) |
| AT (1) | ATE348102T1 (cs) |
| CZ (1) | CZ2005507A3 (cs) |
| DE (1) | DE602005000334T2 (cs) |
| DK (1) | DK1658293T3 (cs) |
| EA (1) | EA009392B1 (cs) |
| ES (1) | ES2273328T3 (cs) |
| NO (1) | NO20060476L (cs) |
| PL (1) | PL1658293T3 (cs) |
| PT (1) | PT1658293E (cs) |
| SI (1) | SI1658293T1 (cs) |
| SK (1) | SK286087B6 (cs) |
| UA (1) | UA86094C2 (cs) |
| WO (1) | WO2006019364A1 (cs) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5923827B2 (ja) * | 1981-12-16 | 1984-06-05 | フエザ−安全剃刀株式会社 | 安全かみそり刃 |
| US20100022774A1 (en) * | 2006-05-25 | 2010-01-28 | Ole Heine Kvernenes | Process useful in the preparation of morphinan antagonists |
| KR100780932B1 (ko) * | 2006-05-30 | 2007-11-30 | 엠텍비젼 주식회사 | 컬러 보간 방법 및 장치 |
| CA2671551C (en) * | 2006-12-04 | 2015-02-10 | Noramco, Inc. | Process for reducing impurities in oxycodone base |
| WO2008070658A1 (en) | 2006-12-04 | 2008-06-12 | Noramco, Inc. | Process for preparing oxycodone having reduced levels of 14-hydroxycodeinone |
| AU2008231127B2 (en) † | 2007-03-23 | 2013-05-02 | SpecGx LLC | Improved preparation of oxymorphone from oripavine |
| GB2450691A (en) * | 2007-07-02 | 2009-01-07 | Alpharma Aps | One-pot preparation of oxycodone from thebaine |
| AU2009294308B2 (en) * | 2008-09-18 | 2013-05-30 | Purdue Pharma L.P. | Pharmaceutical dosage forms comprising poly(e-caprolactone) |
| EP2377866B1 (en) | 2010-03-23 | 2014-02-26 | Siegfried AG | Preparation of low impurity opiates in a continuous flow reactor |
| US8703950B2 (en) | 2010-07-02 | 2014-04-22 | Johnson Matthey Public Limited Co. | Low ABUK oxycodone, its salts and methods of making same |
| TWI643859B (zh) * | 2012-07-16 | 2018-12-11 | 羅德科技公司 | 改良之類鴉片合成方法 |
| TW201639855A (zh) * | 2012-07-16 | 2016-11-16 | 羅德科技公司 | 改良之類鴉片合成方法 |
| RU2639877C2 (ru) * | 2012-08-03 | 2017-12-25 | Джонсон Мэтти Паблик Лимитед Компани | Способ получения оксикодона |
| US9062062B1 (en) | 2013-12-18 | 2015-06-23 | Cody Laboratories, Inc. | Synthesis of oxycodone hydrochloride |
| WO2015095585A2 (en) * | 2013-12-18 | 2015-06-25 | Cody Laboratories, Inc. | Sysnthesis of oxycodone hydrochloride |
| US8846923B1 (en) | 2013-12-18 | 2014-09-30 | Cody Laboratories, Inc. | Preparation of 14-hydroxycodeinone sulfate |
| US10227354B2 (en) | 2013-12-18 | 2019-03-12 | Cody Laboratories, Inc. | Conversion of oxycodone base to oxycodone hydrochloride |
| TWI539952B (zh) | 2014-01-15 | 2016-07-01 | 羅德科技公司 | 改良氧化嗎啡酮合成之方法 |
| WO2015107471A1 (en) | 2014-01-15 | 2015-07-23 | Rhodes Technologies | Process for improved oxycodone synthesis |
| US20160052932A1 (en) * | 2014-08-25 | 2016-02-25 | Johnson Matthey Public Limited Company | Processes for Making Opioids Including 14-Hydroxycodeinone and 14-hydroxymorphinone |
| CN107003304A (zh) * | 2014-12-17 | 2017-08-01 | 西门子医疗保健诊断公司 | 用于羟考酮和羟吗啡酮的测定法的缀合物 |
| US10941154B2 (en) * | 2017-06-20 | 2021-03-09 | Johnson Matthey Public Limited Company | Hydrogenation process for preparing oxycodone hydrochloride from 14-hydroxycodeinone |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6864370B1 (en) * | 2003-06-05 | 2005-03-08 | Zhaiwei Lin | Process for manufacturing oxycodone |
-
2004
- 2004-08-18 SK SK321-2004A patent/SK286087B6/sk not_active IP Right Cessation
-
2005
- 2005-08-09 CZ CZ20050507A patent/CZ2005507A3/cs unknown
- 2005-08-16 AT AT05776280T patent/ATE348102T1/de not_active IP Right Cessation
- 2005-08-16 DE DE602005000334T patent/DE602005000334T2/de not_active Expired - Fee Related
- 2005-08-16 EA EA200600129A patent/EA009392B1/ru not_active IP Right Cessation
- 2005-08-16 SI SI200530007T patent/SI1658293T1/sl unknown
- 2005-08-16 US US10/569,423 patent/US7619087B2/en not_active Expired - Fee Related
- 2005-08-16 UA UAA200702812A patent/UA86094C2/ru unknown
- 2005-08-16 WO PCT/SK2005/000014 patent/WO2006019364A1/en not_active Ceased
- 2005-08-16 ES ES05776280T patent/ES2273328T3/es not_active Expired - Lifetime
- 2005-08-16 PT PT05776280T patent/PT1658293E/pt unknown
- 2005-08-16 EP EP05776280A patent/EP1658293B1/en not_active Expired - Lifetime
- 2005-08-16 PL PL05776280T patent/PL1658293T3/pl unknown
- 2005-08-16 DK DK05776280T patent/DK1658293T3/da active
-
2006
- 2006-01-30 NO NO20060476A patent/NO20060476L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EA200600129A1 (ru) | 2006-06-30 |
| NO20060476L (no) | 2006-03-14 |
| CZ2005507A3 (cs) | 2007-01-31 |
| EP1658293B1 (en) | 2006-12-13 |
| DE602005000334D1 (de) | 2007-01-25 |
| UA86094C2 (en) | 2009-03-25 |
| SK3212004A3 (sk) | 2006-03-02 |
| US20070088162A1 (en) | 2007-04-19 |
| EP1658293A1 (en) | 2006-05-24 |
| DE602005000334T2 (de) | 2007-04-12 |
| ATE348102T1 (de) | 2007-01-15 |
| US7619087B2 (en) | 2009-11-17 |
| DK1658293T3 (da) | 2007-01-29 |
| ES2273328T3 (es) | 2007-05-01 |
| WO2006019364A1 (en) | 2006-02-23 |
| SI1658293T1 (sl) | 2007-04-30 |
| SK286087B6 (sk) | 2008-03-05 |
| EA009392B1 (ru) | 2007-12-28 |
| PL1658293T3 (pl) | 2007-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1658293E (pt) | Método de preparação de oxicodona | |
| SU1508960A3 (ru) | Способ получени производных бензоатных эфиров 3-оксиморфинанов | |
| EP3572401A1 (en) | Ask1 inhibitor and preparation method and use thereof | |
| US11897843B2 (en) | Process for the preparation of enantiomerically enriched 3-aminopiperidine | |
| JPH0432831B2 (cs) | ||
| JP2010043116A (ja) | トロペノールの工業的製造方法 | |
| EP3587420A1 (en) | Tri-cycle compound and applications thereof | |
| CN102295594A (zh) | 4-n-取代-1-(3-甲氧基丙基)-4-哌啶胺类化合物及制备和应用 | |
| EP2397141A1 (en) | Process for the synthesis of beta-amino acids and derivatives thereof | |
| ES2560787T3 (es) | Métodos para producir hidrocodona, hidromorfona o un derivado de las mismas | |
| EP1440075B1 (fr) | Nouveaux derives amides heteroaromatiques de 3beta-amino azabicyclooctane, leur procede de preparation et leurs applications en therapeutique | |
| JPH045289A (ja) | アミド化合物 | |
| US8299258B2 (en) | Method of making piperidine derivatives | |
| CA2368024A1 (en) | Process for preparing [s-(r*,s*)]-.beta.-[[[1-[1-oxo-3-(4-piperidinyl)propyl]-3-piperidinyl]carbonyl]amino]-3-pyridinepropanoic acid and derivatives | |
| KR20130112734A (ko) | 티에노피리미딘 유도체의 결정 | |
| US6861525B2 (en) | Process for the preparation imidazo[1,2-A]pyridine-3-acetamides | |
| US2741609A (en) | N-chjchjchj | |
| CN106316954B (zh) | 制备光学纯(+)-或(－)-n-去甲基美普他酚的方法 | |
| JPS6193184A (ja) | Ｎ−脱メチル−モルフイナンアルカロイドの製造方法 | |
| WO1995000502A1 (en) | Novel intermediate for synthetic use and process for producing aminopiperazine derivative | |
| CN113968841B (zh) | 一种盐酸法舒地尔半水合物的制备方法 | |
| US2741614A (en) | N-isobutylnormorpfflne compounds | |
| RU2772274C2 (ru) | Селективные ингибиторы hdac6, способ их получения и их применение | |
| WO2018228476A1 (zh) | 苯并咪唑类化合物及其应用 | |
| US2915522A (en) | N-tbeta-methyl-mercapto-ethyl |